Aristotle Atlantic Partners »

Olema Pharmaceuticals shares owned by Aristotle Atlantic Partners

Quarter-by-quarter ownership of Olema Pharmaceuticals (OLMA) shares owned by Aristotle Atlantic Partners from 13F filings

Historical chart of Aristotle Atlantic Partners investment in Olema Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Olema Pharmaceuticals held by Aristotle Atlantic Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olema Pharmaceuticals by Aristotle Atlantic Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $372k 25k 14.91

More positions owned by Aristotle Atlantic Partners

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Ametek (AME)
Visa Com Cl A (V)
Darling International (DAR)
Exxon Mobil Corporation (XOM)
Trane Technologies SHS (TT)
Guardant Health (GH)

View all positions for Aristotle Atlantic Partners

Top funds holding Olema Pharmaceuticals

FMR
Paradigm Biocapital Advisors
Bain Capital Life Sciences Investors
Henderson Group
BlackRock
BVF
Siren
Cormorant Asset Management
State Street Corporation
Logos Global Management
Vanguard Capital Management
RA Capital Management
Jennison Associates
Polar Capital Holdings
Geode Capital Management

View all funds holding Olema Pharmaceuticals